Presentations and Details

Oral Podium Presentation

Title: Acrivon Predictive Precision Proteomics (AP3): Next Generation Precision Medicine for Phosphoproteomics-Guided Drug Discovery

Presenter: Lei Shi, Ph.D., Director and Head, AP3 Pathway Discovery, Acrivon Therapeutics

Session: Biotech Spotlight Session 1: Novel Therapeutics

Date and Time: Thursday, July 23, 2026, 3:50–4:00 p.m. ET

Location: Grand Ballroom

Poster Presentation

Title: AP3-guided biological SAR enables discovery of ACR-2316, a novel clinical-stage WEE1/PKMYT1 inhibitor designed for CDK1/2 and PLK1 pathway activation

Poster Number: A082

Session: Poster Session A

Date and Time: Wednesday, July 22, 2026, 6:15–8:45 p.m. ET

Location: Back Bay Ballroom

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.